how-to-better-predict-the-effect-of-your-cancer-immunotherapy-tailored-made-humanized-mouse-models-is-the-key-solution-1

How to better predict the effect of your cancer immunotherapy? Tailored-made humanized mouse models are the key solution

Discover & learn during this webinar: 

  • How to design custom-made humanized immune system (HIS) models for cancer immunotherapy  research
  • Case study & results:  evaluation of immuno-onco biologics & demonstration of antitumor effect in HIS model
  • Parameters to consider for HIS model selection
  • Advantages/limitations of each HIS model
About our speaker Caroline Mignard
Caroline Mignard has obtained a Ph.D in Biology from the University of Strasbourg in France and has more than 15 years of experience in preclinical research.
As study director at Oncodesign, Caroline has been working closely with our clients to select the most appropriate study designs for the evaluation of their therapies through preclinical studies.
Caroline is also involved in IMODI, (Innovative MODels Initiative) a French consortium dedicated to the development, the characterization and the commercialization of new preclinical models in oncology, including PDX models and humanized mouse models. She is the co-author of several publications about PDX models.

Conference animated by :

Intervenant Webikeo

Caroline Mignard

Study Director,

Oncodesign

Christa Vitrouil

Christa Vitrouil

Business & Marketing,

Oncodesign

Florence Fombertasse

Florence Fombertasse

Marketing & Communication Manager,

Oncodesign

Tuesday, January 29th 2019

from 5:00PM to 5:45PM

(CEST)

60 subscribers | 45 mins

Subscription 100% free

Email notifications before the webinar

Chat zone to ask your questions

Replay until February 1, 2020

Be informed of our upcoming webinars, subscribe to our channel.

Oncodesign

Oncodesign

Follow
oncodesign-biotechnology
Followed
126